CAS: 1159637-28-1

Memantine lactose adduct, Min.

Heterocyclic compounds with oxygen hetero-atom(s) only, nesoi

Memantine lactose adduct is a synthetic pharmaceutical compound, which is derived from memantine, a well-known NMDA receptor antagonist, conjugated with lactose. This compound is sourced through chemical synthesis processes that aim to explore alternative formulations and derivatives of memantine to enhance delivery and bioavailability. Memantine acts by blocking the NMDA receptor in the central nervous system, which can prevent excitotoxicity caused by overactivation of glutamate neurotransmission. The conjugation with lactose is hypothesized to facilitate improved pharmacokinetic properties, potentially allowing for better absorption or controlled release. In scientific settings, memantine lactose adduct is primarily researched for its potential applications in treating neurological conditions such as Alzheimer's disease and other cognitive disorders that involve excitotoxic neuronal damage. Researchers are particularly interested in its capacity to provide neuroprotective effects, making it a subject of ongoing preclinical and clinical studies aimed at advancing therapeutic options in neuropharmacology.

Stability Hygroscopic Applications A lactose adduct of Memantine (M218000). Intermediate in the synthesis of reducing carbohydrate Adamantane amines for use in treating Gram positive or Gram negative bacteria infections. References Kustimur, et al.: Chinese Med. J., 116, 633 (2003),

Memantine N-cellobioside is a methylated and fluorinated carbonyl sugar that belongs to the group of saccharides. It is a custom synthesis product with a purity of >98% and the CAS number 1159637-28-1. Memantine N-cellobioside is an oligosaccharide, which means it has more than one sugar unit. It is also a polysaccharide, meaning it contains more than one monosaccharide unit. This product can be used in the modification of other chemicals or in the production of other chemicals.